GSK allows consumers to experience alli via exhibit
GlaxoSmithKline (GSK) is using a public multi-media exhibit in New York City to introduce the weight-loss drug, alli, which will be available in pharmacies and mass retailers around June 15. An online virtual tour of the exhibit is available at myalli.com. The exhibit, called the "alli Experience," is divided into five zones, and begins with a sensory tour that leads to an interactive journey and multi-media education about weight loss realities, such as if someone is ready to commit to a weight loss program. For example, in the third zone, participants can take a test to determine whether they are ready to make a true weight loss commitment or if they are still looking for a quick fix. In zone five, the campaign uses interactive kiosks to help participants find out what is holding them back from achieving their weight-loss goals.
Go to alli <http://www.myalli.com> to see the exhibit online.